DE69922522D1 - Funktionalisierte hyaluronsäurederivate, bildung von hydrogelen und deren verwendung in situ - Google Patents

Funktionalisierte hyaluronsäurederivate, bildung von hydrogelen und deren verwendung in situ

Info

Publication number
DE69922522D1
DE69922522D1 DE1999622522 DE69922522T DE69922522D1 DE 69922522 D1 DE69922522 D1 DE 69922522D1 DE 1999622522 DE1999622522 DE 1999622522 DE 69922522 T DE69922522 T DE 69922522T DE 69922522 D1 DE69922522 D1 DE 69922522D1
Authority
DE
Germany
Prior art keywords
hyaluronic acid
situ
formation
functionalized hyaluronic
hydrogeles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE1999622522
Other languages
English (en)
Other versions
DE69922522T2 (de
Inventor
Daniel Aeschlimann
Paul Bullpitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orthogene Inc
Original Assignee
Orthogene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthogene Inc filed Critical Orthogene Inc
Publication of DE69922522D1 publication Critical patent/DE69922522D1/de
Application granted granted Critical
Publication of DE69922522T2 publication Critical patent/DE69922522T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/80—Hyaluronan
DE69922522T 1998-09-18 1999-09-17 Funktionalisierte hyaluronsäurederivate, bildung von hydrogelen und deren verwendung in situ Expired - Lifetime DE69922522T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/156,829 US6630457B1 (en) 1998-09-18 1998-09-18 Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
US156829 1998-09-18
PCT/EP1999/006913 WO2000016818A1 (en) 1998-09-18 1999-09-17 Functionalized derivatives of hyaluronic acid and formation of hydrogels in situ using same

Publications (2)

Publication Number Publication Date
DE69922522D1 true DE69922522D1 (de) 2005-01-13
DE69922522T2 DE69922522T2 (de) 2005-12-15

Family

ID=22561268

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69922522T Expired - Lifetime DE69922522T2 (de) 1998-09-18 1999-09-17 Funktionalisierte hyaluronsäurederivate, bildung von hydrogelen und deren verwendung in situ

Country Status (8)

Country Link
US (3) US6630457B1 (de)
EP (2) EP1115433B1 (de)
AT (1) ATE284229T1 (de)
AU (1) AU6192299A (de)
CA (1) CA2344215A1 (de)
DE (1) DE69922522T2 (de)
IL (2) IL142068A0 (de)
WO (1) WO2000016818A1 (de)

Families Citing this family (188)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.
JP2001037472A (ja) * 1999-07-28 2001-02-13 Bio Quest:Kk 三次元細胞培養基材及びそれを用いた細胞培養方法
DK1223990T3 (da) 1999-10-15 2004-11-29 Inst Genetics Llc Formuleringer af hyaluronsyre til tilförsel af osteogene proteiner
US20030203030A1 (en) * 2002-01-18 2003-10-30 Control Delivery Systems, Inc. Polymeric gel delivery system for pharmaceuticals
ITPD20020064A1 (it) 2002-03-12 2003-09-12 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem
TWI282283B (en) * 2002-05-17 2007-06-11 Wyeth Corp Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
AU2003299509A1 (en) 2002-06-21 2004-05-13 University Of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
US7034127B2 (en) * 2002-07-02 2006-04-25 Genzyme Corporation Hydrophilic biopolymer-drug conjugates, their preparation and use
WO2004060404A1 (ja) * 2002-12-27 2004-07-22 Chugai Seiyaku Kabushiki Kaisha 薬物担体
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8137688B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
FR2861734B1 (fr) * 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US7641643B2 (en) * 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
DE10318801A1 (de) * 2003-04-17 2004-11-04 Aesculap Ag & Co. Kg Flächiges Implantat und seine Verwendung in der Chirurgie
US8073538B2 (en) * 2003-11-13 2011-12-06 Cardio Polymers, Inc. Treatment of cardiac arrhythmia by modification of neuronal signaling through fat pads of the heart
EP1694712A1 (de) * 2003-12-04 2006-08-30 University of Utah Research Foundation Modifizierte makromoleküle und verfahren zu ihrer herstellung und verwendung
WO2005054302A1 (ja) * 2003-12-05 2005-06-16 Chugai Seiyaku Kabushiki Kaisha 薬物担体及びその製造方法
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
WO2005087289A1 (ja) * 2004-03-15 2005-09-22 Terumo Kabushiki Kaisha 癒着防止材
US8293890B2 (en) 2004-04-30 2012-10-23 Advanced Cardiovascular Systems, Inc. Hyaluronic acid based copolymers
EP1750769B1 (de) * 2004-05-20 2013-01-23 Mentor Worldwide LLC Verfahren zur herstellung eines injizierbaren polymerhydrogels
US8137450B2 (en) * 2004-07-08 2012-03-20 Symatese Collagen-based lyophilised glue and the use thereof for producing an adhesive prosthesis
FR2873379B1 (fr) * 2004-07-23 2008-05-16 Jerome Asius Procede de preparation d'acide hyaluronique reticule, acide hyaluronique reticule susceptible d'etre obtenu par ledit procede, implant contenant ledit acide hyaluronique reticule, et son utilisation
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US20090088846A1 (en) 2007-04-17 2009-04-02 David Myung Hydrogel arthroplasty device
US7235592B2 (en) 2004-10-12 2007-06-26 Zimmer Gmbh PVA hydrogel
MX2007006214A (es) * 2004-11-24 2008-04-16 Therakine Ltd Un implante para suministro de farmaco intraocular.
CN101094680A (zh) * 2004-12-30 2007-12-26 建新公司 用于关节内粘弹性补充的方案
US7825083B2 (en) * 2005-02-10 2010-11-02 Spine Wave, Inc. Synovial fluid barrier
AU2006216655B2 (en) 2005-02-23 2012-05-31 Zimmer Technology, Inc. Blend hydrogels and methods of making
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
US8828433B2 (en) * 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US7858080B2 (en) * 2005-05-20 2010-12-28 Agency For Science, Technology And Research Aldehyde conjugated flavonoid preparations
RU2429018C2 (ru) * 2005-07-06 2011-09-20 Сейкагаку Корпорейшн Гель, полученный из фотосшитой гиалуроновой кислоты с введенным лекарственным средством
KR20080080481A (ko) * 2005-09-02 2008-09-04 콜바르 라이프사이언스 리미티드 교차-결합된 다당류 및 단백질 매트릭스 및 그의 제조 방법
WO2007035778A2 (en) 2005-09-19 2007-03-29 Histogenics Corporation Cell-support matrix and a method for preparation thereof
JP2009513207A (ja) 2005-10-27 2009-04-02 コロプラスト アクティーゼルスカブ Ｅｃｍ材料を伴う生分解性足場
DE602006019474D1 (de) * 2005-11-22 2011-02-17 Ard Sa Hren dafür und verwendungen davon
US8262730B2 (en) 2005-12-07 2012-09-11 Zimmer, Inc. Methods of bonding or modifying hydrogels using irradiation
JP2007177244A (ja) 2005-12-22 2007-07-12 Zimmer Inc ペルフルオロシクロブタン架橋ハイドロゲル
EP2492285A1 (de) 2006-03-07 2012-08-29 ProChon Biotech Ltd. Hydrazidderivate von Hyaluronsäure
US8110242B2 (en) 2006-03-24 2012-02-07 Zimmer, Inc. Methods of preparing hydrogel coatings
MX2008012837A (es) * 2006-04-07 2008-10-17 Adocia Polisacaridos bifuncionalizados.
US7674781B2 (en) * 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
KR100803576B1 (ko) * 2006-06-14 2008-02-15 주식회사 인피트론 지방줄기세포 및 지방세포를 포함한 이식용 조성물
EP1884231A1 (de) * 2006-08-01 2008-02-06 Auriga International S.A. Kosmetische oder Pharmazeutische Zusammensetzung, die Hyaluronsäure enthält
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
FR2908415B1 (fr) * 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
ATE545436T1 (de) * 2006-12-22 2012-03-15 Croma Pharma Ges M B H Verwendung von thiolierten polysacchariden zum gewebeaufbau
WO2008081463A2 (en) * 2007-01-04 2008-07-10 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
WO2008147867A2 (en) 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
US20110077737A1 (en) * 2007-07-30 2011-03-31 Allergan, Inc. Tunably Crosslinked Polysaccharide Compositions
US7731988B2 (en) 2007-08-03 2010-06-08 Zimmer, Inc. Multi-polymer hydrogels
US8062739B2 (en) 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
US7947784B2 (en) 2007-11-16 2011-05-24 Zimmer, Inc. Reactive compounding of hydrogels
WO2009065116A1 (en) 2007-11-16 2009-05-22 Aspect Pharmaceuticals Llc Compositions and methods for treating purpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US20100279952A1 (en) * 2007-12-21 2010-11-04 Ninus Caram-Lelham Cross-linked hydrogel containing an active substance
US8034362B2 (en) 2008-01-04 2011-10-11 Zimmer, Inc. Chemical composition of hydrogels for use as articulating surfaces
EP2249891B1 (de) 2008-02-13 2016-05-25 The Cleveland Clinic Foundation Molekulare verstärkung von extrazellulärer matrix und anwendungsverfahren
US8668863B2 (en) 2008-02-26 2014-03-11 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
WO2009108100A1 (en) * 2008-02-29 2009-09-03 Ipr-Systems Sweden Ab Composition for the formation of gels
WO2009135029A2 (en) 2008-04-30 2009-11-05 The Cleveland Clinic Foundation Compositions and methods to treat urinary incontinence
WO2009148985A2 (en) * 2008-06-03 2009-12-10 E. I. Du Pont De Nemours And Company A tissue coating for preventing undesired tissue-to-tissue adhesions
US20120209396A1 (en) 2008-07-07 2012-08-16 David Myung Orthopedic implants having gradient polymer alloys
US8883915B2 (en) 2008-07-07 2014-11-11 Biomimedica, Inc. Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same
US20100015231A1 (en) * 2008-07-17 2010-01-21 E.I. Du Pont De Nemours And Company Low swell, long-lived hydrogel sealant
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
WO2010017282A1 (en) 2008-08-05 2010-02-11 Biomimedica, Inc. Polyurethane-grafted hydrogels
ES2829971T3 (es) 2008-09-02 2021-06-02 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos
DE102008048227A1 (de) 2008-09-18 2010-04-01 Friedrich-Schiller-Universität Jena Verfahren zur Generierung von formstabilen Polyelektrolythydrogel-Körpern mit definierter dreidimensionaler Gestalt sowie deren Verwendung
KR101789337B1 (ko) 2008-10-02 2017-10-23 엘.알.알.앤드 디 리미티드 계면층 상처 드레싱
CN101721349B (zh) 2008-10-16 2011-07-20 常州百瑞吉生物医药有限公司 可注射原位交联水凝胶及其制备方法和用途
US9044529B2 (en) * 2008-11-19 2015-06-02 Actamax Surgical Materials, Llc Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether
US20100160960A1 (en) * 2008-12-19 2010-06-24 E. I. Du Pont De Nemours And Company Hydrogel tissue adhesive having increased degradation time
US8273373B2 (en) * 2008-12-30 2012-09-25 Case Western Reserve University Photocrosslinked biodegradable hydrogel
US8968733B2 (en) 2009-02-21 2015-03-03 Sofradim Production Functionalized surgical adhesives
DK2413894T3 (en) * 2009-04-02 2017-04-03 Allergan Inc HIGHLY FORMED HYDROGLES FOR SOFTWARE STRENGTH
US8951989B2 (en) 2009-04-09 2015-02-10 Actamax Surgical Materials, Llc Hydrogel tissue adhesive having reduced degradation time
KR101100803B1 (ko) * 2009-04-24 2011-12-29 서울과학기술대학교 산학협력단 리포아마이드가 결합된 고분자화합물과 이의 제조방법
WO2010138074A1 (en) * 2009-05-29 2010-12-02 Hilborn Joens Hyaluronic acid based delivery systems
EP2435504B1 (de) 2009-05-29 2020-03-11 Agency For Science, Technology And Research Flavonoid hydrogel
IT1399351B1 (it) * 2009-06-16 2013-04-16 Fidia Farmaceutici Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi
EP2448604B1 (de) 2009-07-02 2016-03-23 Actamax Surgical Materials LLC Hydrogel-gewebekleber zum medizinischen gebrauch
US8796242B2 (en) 2009-07-02 2014-08-05 Actamax Surgical Materials, Llc Hydrogel tissue adhesive for medical use
WO2011002956A1 (en) * 2009-07-02 2011-01-06 E. I. Du Pont De Nemours And Company Aldehyde-functionalized polysaccharides
JP2013506681A (ja) * 2009-10-02 2013-02-28 バクスター・インターナショナル・インコーポレイテッド 腎損傷の処置における使用のための造血幹細胞
WO2011044367A1 (en) 2009-10-07 2011-04-14 Genogen, Inc. Methods and compositions for skin regeneration
NZ599527A (en) 2009-11-09 2014-04-30 Spotlight Technology Partners Llc Fragmented hydrogels
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
US20120301441A1 (en) * 2009-11-11 2012-11-29 Hermanus Bernardus Johannes Karperien Dextran-hyaluronic acid based hydrogels
US9132201B2 (en) * 2009-11-11 2015-09-15 University Of Twente, Institute For Biomedical And Technical Medicine (Mira) Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers
WO2011065916A1 (en) 2009-11-24 2011-06-03 Agency For Science, Technology And Research Crosslinking branched molecule through thiol-disulfide exchange to form hydrogel
CN102648214B (zh) * 2009-12-08 2015-02-18 丘比株式会社 纯化透明质酸类的制造方法
CZ302504B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
FR2954945B1 (fr) * 2010-01-04 2012-01-06 Oreal Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
CA2792729C (en) 2010-03-12 2016-06-28 Allergan Industrie, Sas Fluid compositions for improving skin conditions
EP3078388B1 (de) 2010-03-22 2019-02-20 Allergan, Inc. Vernetzte hydrogele zur weichgewebevergrösserung
US9012415B2 (en) 2010-03-26 2015-04-21 Stemmatters, Biotecnologia E Medicina Regenerativa S.A. Photo-crosslinked gellan gum-based hydrogels: preparation methods and uses thereof
CN107260684A (zh) * 2010-03-29 2017-10-20 赢创有限公司 用于在局部给药位点改进药物组合物的滞留的组合物和方法
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
CN102399295B (zh) 2010-09-09 2013-11-06 常州百瑞吉生物医药有限公司 低巯基化改性度生物相容高分子巯基化衍生物及其交联材料和用途
WO2012048283A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
JP6042815B2 (ja) 2010-10-08 2016-12-14 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム 生物医学的応用のためのアルギン酸塩及びヒアルロン酸を用いる抗癒着性バリア膜
WO2012054784A1 (en) 2010-10-20 2012-04-26 Li-Cor, Inc. Fluorescent imaging with substituted cyanine dyes
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
EP2670439B1 (de) * 2011-01-31 2019-03-13 PVAC Medical Technologies Ltd. Wirkstoff zur abschwächung unerwünschter medizinischer zustände
SI2682409T1 (sl) 2011-03-03 2017-08-31 Chugai Seiyaku Kabushiki Kaisha Derivat hialuronske kisline modificiran z amino-karboksilno kislino
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
AU2012245517B2 (en) 2011-04-20 2015-07-30 Carbylan Therapeutics, Inc. In-situ gel forming compositions
JPWO2012165462A1 (ja) * 2011-05-31 2015-02-23 国立大学法人 東京大学 ハイドロゲル及びその製造方法
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20220023186A1 (en) * 2011-06-03 2022-01-27 Allergan, Inc. Dermal filler compositions
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
KR102238406B1 (ko) 2011-06-03 2021-04-08 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
TW201322988A (zh) * 2011-09-08 2013-06-16 Shin Poong Pharmaceutical Co 關節炎之治療注射劑
AU2015255254B2 (en) * 2011-09-14 2017-07-06 Allergan Industrie, Sas Dermal filler compositions for fine line treatment
US20130103157A1 (en) 2011-10-03 2013-04-25 Lampros Kourtis Polymeric adhesive for anchoring compliant materials to another surface
TWI561535B (en) 2011-10-06 2016-12-11 Bvw Holding Ag Copolymers of hydrophobic and hydrophilic segments that reduce protein adsorption
CA2856512A1 (en) 2011-11-21 2013-05-30 Biomimedica, Inc. Systems, devices, and methods for anchoring orthopaedic implants to bone
PT2806908T (pt) * 2012-01-25 2020-06-22 Univ Akron Hidrogéis fluorados polimerizáveis para pensos de feridas e métodos para os fazer
WO2013126590A2 (en) 2012-02-21 2013-08-29 Baxter International Inc. Pharmaceutical composition comprising cd34+ cells
CZ2012136A3 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
CZ304512B6 (cs) * 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
CZ304266B6 (cs) 2012-11-27 2014-02-05 Contipro Biotech S.R.O. Nekonečná vlákna na bázi hyaluronanu selektivně oxidovaného v poloze 6 N-acetyl-D-glukosaminové části, jejich příprava, použití, nitě, střiže, příze, textilie a způsob jejich úpravy
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
US20140315828A1 (en) 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
EP3027659B1 (de) 2013-07-29 2020-12-09 Actamax Surgical Materials LLC Gewebeklebstoff mit niedriger schwellung und dichtungsmittelzusammensetzungen
US9782345B2 (en) 2013-10-17 2017-10-10 Jade Therapeutics, Inc. Ocular composition and method
CZ2014150A3 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
WO2015142721A1 (en) * 2014-03-16 2015-09-24 Drexel University Novel hydrogels and methods using same
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
US10722444B2 (en) 2014-09-30 2020-07-28 Allergan Industrie, Sas Stable hydrogel compositions including additives
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
EP3040348A1 (de) * 2014-12-29 2016-07-06 Galderma S.A. Pfropfcopolymer
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ2015398A3 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
US11077228B2 (en) 2015-08-10 2021-08-03 Hyalex Orthopaedics, Inc. Interpenetrating polymer networks
US10563164B1 (en) 2015-10-08 2020-02-18 Charm Sciences, Inc. Plate reader
EP3156044A1 (de) 2015-10-16 2017-04-19 Merz Pharma GmbH & Co. KGaA In-situ-vernetzbare polysaccharidzusammensetzungen und verwendungen davon
EP3397650A1 (de) 2015-12-29 2018-11-07 Galderma S.A. Hydrolyse von esterbindungen in amidvernetzten glykosaminoglykanen
US10495563B1 (en) 2016-04-28 2019-12-03 Charm Sciences, Inc. Plate reader observation methods and operation
EP3241895A1 (de) * 2016-05-04 2017-11-08 ETH Zürich, ETH Transfer Transglutaminasevermittelte hyaluronanhydrogele mit hohem molekulargewicht
PT3623390T (pt) * 2016-05-31 2023-10-27 Galderma Sa Reticulador de hidrato de carbono
US11491233B2 (en) * 2016-06-13 2022-11-08 Purdue Research Foundation Responsive elastic polymers and methods of making and using same
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
US10300169B2 (en) 2016-08-24 2019-05-28 Allergan, Inc. Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
US10993919B2 (en) * 2016-10-04 2021-05-04 University Of Florida Research Foundation, Inc. Chondroprotective nanoparticles for the treatment of osteoarthritis
KR101877894B1 (ko) * 2016-12-09 2018-07-12 서울대학교병원 난청 치료용 복합 주사 제제 및 그의 제조 방법
SG11201908547VA (en) 2017-03-22 2019-10-30 Genentech Inc Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
US11129790B2 (en) 2017-05-19 2021-09-28 Northeastern University Chemo-enzymatic site-specific modification of peptides and proteins to form cleavable conjugates
US20230190997A1 (en) 2017-06-26 2023-06-22 Evolved By Nature, Inc. Silk-hyaluronic acid based tissue filers and methods of using the same
WO2019121488A1 (en) * 2017-12-21 2019-06-27 Nicox S.A. Nitric oxide releasing hyaluronic esters
CN108721695A (zh) * 2018-05-29 2018-11-02 金陵科技学院 一种可注射性复合水凝胶细胞载体支架的制备方法
CA3101412A1 (en) 2018-06-15 2019-12-19 Croma-Pharma Gmbh Hydrogel composition comprising a crosslinked polymer
AR115549A1 (es) 2018-06-15 2021-02-03 Croma Pharma Gmbh Composición de hidrogel que comprende un polímero reticulado
US10869950B2 (en) 2018-07-17 2020-12-22 Hyalex Orthopaedics, Inc. Ionic polymer compositions
TW202041221A (zh) 2018-12-19 2020-11-16 德商梅茲製藥有限兩合公司 修飾透明質酸衍生物及其製備方法、其應用、其用途、交聯的水凝膠及其製備方法、用於原位形成其之套組
US11667895B2 (en) 2019-05-10 2023-06-06 The Board Of Trustees Of The University Of Alabama Methods and devices related to controlled delivery of phages as a theranostic tool
CN110279610B (zh) 2019-06-26 2021-06-11 常州百瑞吉生物医药有限公司 一种透明质酸皮肤保护组合物及其制备方法和应用
US20230133656A1 (en) * 2019-07-03 2023-05-04 Molly Sandra Shoichet Hydrogel compositions and uses thereof
AU2020395955A1 (en) 2019-12-02 2022-07-14 Galderma Holding SA High molecular weight esthetic compositions
US20220403054A1 (en) 2019-12-19 2022-12-22 Croma-Pharma Gmbh Thiol-modified hyaluronan and hydrogel comprising the crosslinked hyaluronan
CN113929792B (zh) * 2020-07-13 2023-03-10 孛朗孚(杭州)生物科技有限公司 一种醛基化修饰的透明质酸(钠)及其合成方法和应用
CN113583262B (zh) * 2021-06-24 2022-03-29 四川大学 用于关节软骨修复的近红外响应透明质酸水凝胶及其制备方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166331A (en) 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US5512329A (en) * 1982-09-29 1996-04-30 Bsi Corporation Substrate surface preparation
US4517295A (en) 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
US5316926A (en) 1983-11-25 1994-05-31 Miles Inc. Method for the microbiological production of non-antigenic hyaluronic acid
MX163953B (es) 1984-03-27 1992-07-03 Univ New Jersey Med Procedimiento para preparar una matriz biodegradable a base de colageno
JPS60251898A (ja) 1984-05-25 1985-12-12 Shiseido Co Ltd 醗酵法によるヒアルロン酸の製造方法
US4582865A (en) 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4780414A (en) 1985-01-18 1988-10-25 Bio-Technology General Corp. Method of producing high molecular weight sodium hyallronate by fermentation of streptococcus
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
DE3608158A1 (de) 1986-03-12 1987-09-17 Braun Melsungen Ag Mit vernetzter gelatine impraegnierte gefaessprothese und verfahren zu ihrer herstellung
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US5527893A (en) 1987-09-18 1996-06-18 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US5017229A (en) 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
DE68926051T2 (de) 1988-12-20 1996-08-29 Jolla Cancer Res Found Polypeptid-polymer-konjugate mit wundheilender wirkung
US4897349A (en) 1989-04-28 1990-01-30 Medchem Products, Inc. Biosynthesis of hyaluronic acid
US5356883A (en) 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
CA2070672C (en) * 1990-10-18 2002-10-08 Kazuo Akima Compound of medicinal ingredient and hyaluronic acid and process for producing the same
US5206023A (en) 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5219360A (en) * 1991-05-10 1993-06-15 Fortis Research Corporation Mammary prosthesis fill and method of making same
WO1993000050A1 (en) * 1991-06-21 1993-01-07 Genetics Institute, Inc. Pharmaceutical formulations of osteogenic proteins
FR2679778B1 (fr) 1991-08-02 1995-07-07 Coletica Utilisation de collagene reticule par un agent de reticulation pour la fabrication d'une membrane suturable, biocompatible, a resorption lente, ainsi qu'une telle membrane.
US5270300A (en) 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
GB2261672A (en) 1991-11-18 1993-05-26 Michael Braden The use of biomaterials for tissue repair
JP2855307B2 (ja) * 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
GB9206509D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
IL105529A0 (en) 1992-05-01 1993-08-18 Amgen Inc Collagen-containing sponges as drug delivery for proteins
US5565210A (en) 1993-03-22 1996-10-15 Johnson & Johnson Medical, Inc. Bioabsorbable wound implant materials
US5616568A (en) 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
IT1268955B1 (it) * 1994-03-11 1997-03-18 Fidia Advanced Biopolymers Srl Esteri attivi di polisaccaridi carbossilici
US5769899A (en) 1994-08-12 1998-06-23 Matrix Biotechnologies, Inc. Cartilage repair unit
US6025444A (en) * 1994-11-17 2000-02-15 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Cinnamic acid derivative
IT1269274B (it) 1994-11-22 1997-03-26 Carlo Antonio Camorani Metodo per la formatura di piastrelle ceramiche ed impianto relativo
US5693341A (en) 1995-03-16 1997-12-02 Collagen Corporation Affinity bound collagen matrices for the delivery of biologically active agents
US5817303A (en) * 1995-05-05 1998-10-06 Protein Polymer Technologies, Inc. Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
AU722250B2 (en) 1995-11-15 2000-07-27 Seikagaku Corporation Photocured crosslinked-hyaluronic acid gel and method of preparation thereof
US5939323A (en) 1996-05-28 1999-08-17 Brown University Hyaluronan based biodegradable scaffolds for tissue repair
FR2754267B1 (fr) 1996-10-07 1999-01-22 Dev Des Utilisations Du Collag Procede de reticulation de collagene ou de gelatine a l'aide d'un polyaldehyde macromoleculaire et composition adhesive
CA2328698A1 (en) * 1998-04-28 1999-11-04 Jagotec Ag Hyaluronan-based imaging agents
EP1082963A4 (de) * 1998-05-20 2004-03-17 Chugai Pharmaceutical Co Ltd Arzneimittel für hyaluronsäure-assozierte gelenkkrankheiten

Also Published As

Publication number Publication date
EP1115433B1 (de) 2004-12-08
WO2000016818A9 (en) 2000-08-24
ATE284229T1 (de) 2004-12-15
US20070149441A1 (en) 2007-06-28
AU6192299A (en) 2000-04-10
WO2000016818A1 (en) 2000-03-30
EP1115433A1 (de) 2001-07-18
US20040072793A1 (en) 2004-04-15
EP1757314A1 (de) 2007-02-28
US7196180B2 (en) 2007-03-27
CA2344215A1 (en) 2000-03-30
IL142068A0 (en) 2002-03-10
DE69922522T2 (de) 2005-12-15
US6630457B1 (en) 2003-10-07
IL142068A (en) 2006-10-05

Similar Documents

Publication Publication Date Title
DE69922522D1 (de) Funktionalisierte hyaluronsäurederivate, bildung von hydrogelen und deren verwendung in situ
ATE253622T1 (de) Dichtungsmaterial, abdichtung sowie verfahren zur abdichtung von öffnungen und deren verwendung
EP1375537A3 (de) Wasserabsorbierende Polymere mit supermolekularen Hohlraummolekülen, Verfahren zu deren Herstellung und deren Verwendung
BR0001290B1 (pt) processo para imppressão contìnua, silmultánea ou consecutiva de uma tira de membrana de eletrólito de polìmero com camadas de eletrodo.
ATE370946T1 (de) 16-halogen-epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung
DE602004028729D1 (de) Immobilisationsträger, verfahren zu dessen herstellung, elektrode, verfahren zu deren herstellung, vorrichtung unter verwendung der elektrodenreaktion und verfahren zu deren herstellung
ATE310769T1 (de) Polymere produkte enthaltend modifizierte kohlenstoffprodukte sowie verfahren zur herstellung und ihre verwendung
DE714561T1 (de) Trennmembran für elektrolytische polymerzelle und verfahren für deren herstellung
DE60143192D1 (de) Zellen zur entdeckung von medikamenten
DE602005024804D1 (de) Polymere strukturen und verfahren zu deren herstellung
DE60037572D1 (de) Zur bildung von wasserstoffbrückenbindungen befähigte, polysiloxanabschnitte enthaltende synthetische polymere
ATE241948T1 (de) Wasserabsorbierende polymere mit hohlraumverbindungen, verfahren zu deren herstellung und deren verwendung
DE69937411D1 (de) Klebstoffe auf basis von polyharnstoff, gegenstände davon, und verfahren zu ihrer herstellung und verwendung
DE50306191D1 (de) Protonenleitende polymermembran sowie verfahren zu deren herstellung
ATA182898A (de) Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
DE59603494D1 (de) Polymerelektrolyte und verfahren zu deren herstellung
DE19881845D2 (de) Verfahren zur Pfropfung von Lignin, danach hergestellte Polymerisate und deren Verwendung
DE69732033D1 (de) POLYPROPYLENZUSAMMENSETZUNG,VERFAHREN ZU DEREN HERSTELLUNG UND POLYMERISATIONSKATALYSATOR DAFüR
DE69810781T2 (de) Polydisperses propylenpolymer und verfahren zu dessen herstellung
ATE327257T1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
DE69832147D1 (de) Kaltgewalztes, dickes stahlblech mit hervorragenden tiefzieheigenschaften und verfahren zu dessen herstellung
ATE447413T1 (de) Konjugate und verfahren zu deren herstellung sowie deren verwendung zum transport von molekülen über biologische membranen
DE69615159T2 (de) Verfahren zur herstellung von epoxidiertem organischem polymer, thermoplastische harzzusammensetzung, primerzusammensetzung, nicht-vulkanisierte kautschukzusammensetzung, kautschukformmassen und verfahren zu deren herstellung
DE60307830D1 (de) Neue multimerische moleküle, verfahren zu deren herstellung, und deren verwendung zur herstellung von arzneimitteln
DE59804239D1 (de) Neues kalalysatorsystem, dessen verwendung zur polymerisation von dienen in lösung, suspension und gasphase und verwendung der somit herstellbaren dienkautschuke

Legal Events

Date Code Title Description
8364 No opposition during term of opposition